IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Medgenics
Symbol: MDGN
Price: Last trade $7.79
Trade Date: 10/1
Shares: TBD
Underwriter(s) Piper Jaffray, JMP Securities
CoManager(s) Needham & Co.
Rating=Subscription Needed
Company: Concho Resources
Symbol: CXO
Price: Last trade $98.30
Trade Date: 10/1
Shares: 7 million
Underwriter(s) J.P. Morgan, Credit Suisse
Rating=Subscription Needed
Secondaries announced 9.30.2015